BCRX Financial Facts
General and administrative: 3.28MInterest and other income: 92K
See Full Income Statement
Deferred rent: 138K
Marketable securities: 21.56M
See Full Balance Sheet
BioCryst Pharmaceuticals, Inc. (BCRX) Earnings
|
Expand Research on BCRX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -10.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/9/22 | Q222 | N/A | -$0.34 | N/A | N/A | $63.5M | N/A | N/A | N/A | ||
| 3/4/19 | Q418 | -$0.25 | -$0.25 | $0.00 | $2.73M | $2.82M | N/A |  | | Details | |
| 11/6/18 |  |
Q318 | -$0.28 | -$0.25 | -$0.03 | $1.5M | $3.77M | N/A | | | Details |
| 2/27/18 | |
Q417 | -$0.20 | -$0.15 | -$0.05 | $3.9M | $4.93M | N/A | | | Details |
| 11/7/17 | |
Q317 | -$0.18 | -$0.19 | +$0.01 | $8.8M | $4.62M | N/A | | | Details |
| 8/7/17 | Q217 | -$0.21 | -$0.19 | -$0.02 | $3.1M | $5.79M | N/A | | | Details | |
| 5/4/17 | |
Q117 | -$0.19 | -$0.19 | $0.00 | $9.4M | $5.26M | N/A | | | Details |
| 2/27/17 | Q416 | -$0.06 | -$0.23 | +$0.17 | $9M | $4.13M | N/A | | | Details |
